Catalyst Wire Dossier Catalyst Wire Dossier

Nabiximols

tetrahydrocannabinol and cannabidiol oromucosal spray · GW Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Nabiximols, covering 2016-08-11 to 2025-07-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders [Phase 2]

See pricing